Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2012 Sep 26;287(47):39742–39752. doi: 10.1074/jbc.M112.394932

Activation of Cholera Toxin Production by Anaerobic Respiration of Trimethylamine N-oxide in Vibrio cholerae*

Kang-Mu Lee ‡,1, Yongjin Park ‡,1, Wasimul Bari , Mi Young Yoon , Junhyeok Go , Sang Cheol Kim §, Hyung-il Lee , Sang Sun Yoon ‡,‖,**,2
PMCID: PMC3501055  PMID: 23019319

Background: The human intestine, in which Vibrio cholerae exerts its virulence, is an anaerobic environment.

Results: When grown anaerobically with trimethylamine N-oxide (TMAO), V. cholerae exhibited enhanced growth and cholera toxin (CT) production was remarkably induced.

Conclusion: Anaerobic TMAO respiration may serve as a signal to increase V. cholerae virulence.

Significance: A novel growth condition that induces CT production is uncovered.

Keywords: Bacterial Pathogenesis, Bacterial Toxins, Cholera Toxin, Respiration, Virulence Factors, Anaerobic Respiration, Trimethylamine N-Oxide, Vibrio Cholerae

Abstract

Vibrio cholerae is a Gram-negative bacterium that causes cholera. Although the pathogenesis caused by this deadly pathogen takes place in the intestine, commonly thought to be anaerobic, anaerobiosis-induced virulence regulations are not fully elucidated. Anerobic growth of the V. cholerae strain, N16961, was promoted when trimethylamine N-oxide (TMAO) was used as an alternative electron acceptor. Strikingly, cholera toxin (CT) production was markedly induced during anaerobic TMAO respiration. N16961 mutants unable to metabolize TMAO were incapable of producing CT, suggesting a mechanistic link between anaerobic TMAO respiration and CT production. TMAO reductase is transported to the periplasm via the twin arginine transport (TAT) system. A similar defect in both anaerobic TMAO respiration and CT production was also observed in a N16961 TAT mutant. In contrast, the abilities to grow on TMAO and to produce CT were not affected in a mutant of the general secretion pathway. This suggests that V. cholerae may utilize the TAT system to secrete CT during TMAO respiration. During anaerobic growth with TMAO, N16961 cells exhibit green fluorescence when stained with 2′,7′-dichlorofluorescein diacetate, a specific dye for reactive oxygen species (ROS). Furthermore, CT production was decreased in the presence of an ROS scavenger suggesting a positive role of ROS in regulating CT production. When TMAO was co-administered to infant mice infected with N16961, the mice exhibited more severe pathogenic symptoms. Together, our results reveal a novel anaerobic growth condition that stimulates V. cholerae to produce its major virulence factor.

Introduction

Cholera is an acute noninflammatory diarrheal disease that affects humans infected with the causative pathogen Vibrio cholerae (1). Cholera has been involved in seven historic pandemics and has posed a huge threat to human health in regional epidemics until very recently (2). Among more than 200 O-antigen serotypes, O1 and O139 serotypes are toxigenic and can cause cholera. O1 serotype strains are further classified into two biotypes, El Tor and Classical, the latter of which is presumed extinct (3). Invading V. cholerae cells that survive the acidic gastric environment enter the intestine, where they produce an array of virulence factors, including cholera toxin (CT)3 and toxin co-regulated pilus (TCP) (4). CT is an ADP ribosylating toxin that creates imbalanced ion transport across the intestinal epithelia leading to loss of electrolytes and water from the epithelial cells (5). TCP is known to play an essential role in the bacterial colonization to the intestinal surface (6). Human intestine is occupied with commensal bacteria, most of which are strict anaerobes (7). This suggests that (i) the microenvironment in the human intestine is anaerobic and (ii) anaerobiosis may serve as a host factor that modulates V. cholerae virulence (8). Consistent with this notion, recent reports showed that under anaerobic conditions, expression of tcpP, a regulator of virulence gene expression (9) was elevated and this increase was mediated by a novel oxygen sensing mechanism of AphB, a LysR-type transcriptional activator (10, 11). These findings were achieved from V. cholerae cells grown anaerobically in AKI media.

As a facultative anaerobe, V. cholerae can support its growth by fermentation of diverse carbohydrates including glucose, sucrose, maltose, mannitol, lactose, dextrin, and starch (12, 13). Sucrose fermentation has been used as a basis for the identification of V. cholerae species among fecal isolates (14). However, whether V. cholerae can also support anaerobic growth by respiration of alternative electron acceptors (AEAs) has not been extensively studied. In addition, studies have not been conducted on (i) which AEA can most efficiently stimulate anaerobic growth of V. cholerae, (ii) how anaerobic respiration contributes to bacterial proliferation in the human intestine, and (iii) how V. cholerae virulence is regulated under such anaerobic respiratory growth.

The genome of the 7th pandemic strain N16961 contains several genes that are likely involved in anaerobic respiration. It appears that N16961 is capable of utilizing fumarate, nitrate, trimethylamine N-oxide (TMAO), or dimethyl sulfoxide (DMSO) as AEAs (15). In this study, we investigated the anaerobic growth and virulence regulation of N16961 under diverse anaerobic respiration conditions. N16961 grew better and secreted remarkably high amounts of CT while growing anaerobically with TMAO. We also uncovered the possible mechanisms for enhanced CT production and explored the potential in vivo relevance of anaerobic TMAO respiration. This report reveals novel features associated with V. cholerae virulence during a growth mode that may occur inside the human intestine.

EXPERIMENTAL PROCEDURES

Ethics Statement

All animal experiments were conducted following the national guidelines provided by the Korean government (Ministry for Food, Agriculture, Forestry and Fisheries) and in strict accordance with the institutional guidelines for animal care and use of laboratory animals. The methods for animal experimentations using infant mice were approved by the Committee on the Ethics of Animal Experiments of the Yonsei University College of Medicine (permit number 2011-0166).

Bacterial Strains and Growth

Bacterial strains and plasmids used in this study are listed in Table 1. Bacterial cultures were grown at 37 °C in Luria-Bertani media (LB, 10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl/liter). The anaerobic growth of V. cholerae strains was performed as described elsewhere (16). To support anaerobic growth, trimethylamine N-oxide, dimethyl sulfoxide, or fumarate (Sigma) was added to the medium and termed LBT, LBD, or LBF, respectively.

TABLE 1.

Bacterial strains and plasmid used in this study

Strains or plasmids Relevant characteristics Ref. or source
V. cholerae strains
    N16961 O1, El Tor Lab collection
    N16961 PctxAB::lacZ fusion ctxAB promoter lacZ fusion construct This study
    ΔVC1720 N16961, VC1720::TnKGL3 This study
    ΔVC0116 N16961, VC0116::TnKGL3 This study
    ΔVC2053 N16961, VC2053::TnKGL3 This study
    ΔVC1024 N16961, VC1024::TnKGL3 This study
    N16961 Δtat mutant N16961, VC0086-VC0088 deleted This study
    N16961 Δsec mutant N16961, VC0742-VC0744 deleted This study
    N16961 Δtype II mutant N16961, VC2723-VC2734 deleted This study
    O395 O1, Classical Lab collection
    C6706 O1. El Tor Lab collection
    569B O1, Classical Lab collection
    MO10 O139 Lab collection
    AM19226 Non-O1, non-O139 Lab collection
    CVD115 hap, rtxA double mutant of CVD110 (24)

E. coli strain
    SM10/λpir Kmr thi-1 thr leu tonA lacY supE recA::RP4–2-Tc::Mu pir+, for conjugal transfer Lab collection

Plasmids
    pCVD442 sacB suicide vector from plasmid pUM24 Lab collection
    pVIK112 Suicide vector for lacZ reporter fusion, Kmr Lab collection
    pTnKGL3 Suicide vector bearing TnKGL3, Cmr Kmr Lab collection
CT ELISA and Western Blot Analysis

CT ELISA was performed as previously described (17). Purified CT (List Biological Laboratories, Inc., Campbell, CA) was used to provide a standard curve. For Western blot analysis, culture supernatants were first concentrated via TCA (trichloroacetic acid, Sigma) precipitation (18). Western blot analysis was carried out as previously described (19). Rabbit polyclonal antibody raised against CT subunit B (Abcam Inc., Cambridge, UK) was used for both assays.

Transposon (Tn) Mutant Screening

A library of Tn-insertion mutants was constructed by the conjugal transfer of TnKGL3, a mariner-based Tn (3). Kmr mutants (>20,000) were screened for their capability to grow anaerobically on LB agar plates containing 50 mm TMAO. N16961 mutants found to form smaller-sized colonies after 2 days of anaerobic growth were selected and individually tested in broth cultures. Arbitrary PCR was performed to determine the location of the Tn insertion site. Information regarding primer sequences and PCR protocol are described elsewhere (3).

Construction of Mutants and ctxAB Promoter-lacZ Fusion Strain

V. cholerae mutants were created by allele replacement as previously described (20). The 500-base pair flanking sequences located at both ends to introduce mutation were amplified by PCR with the primers listed in Table 2. Construction of a single-copy PctxAB::lacZ transcriptional fusion and β-galactosidase activity assay were performed as described previously (3).

TABLE 2.

Primers used in this study

Gene name Directiona Primer sequence (5′-3′)b
Cloning
    ctxA-promoter fusion F CACATGAATTCACTATCGAGTCAGAGCAATCCG
    ctxA-promoter fusion R ATTGGTCTAGATTGTTTAACAGAAAAATAATTGATCAAAAC
    tatABC Left F CTCTAGTCGACACTGCTGTATGTCGAAGGCTTGG
    tatABC Left R GAATTGAGCTCGATAAGAAGTTGCCAAATACTGATACCACC
    tatABC Right F CACTAGAGCTCAAGCGTCCATACATTATCGTTGGTG
    tatABC Right R GAATTCCCGGGTCAGCGAGGTAAGAACGACTTTCATAA
    yajC-secD-secF Left F AACCTGTCGACGGTGTGCGTCGTGGTATCGACA
    yajC-secD-secF Left R GATATGAGCTCGCCTGCGGCATGTGCTACAGAA
    yajC-secD-secF Right F AACCTGAGCTCAATGATCCACGGTTTTGCGCTG
    yajC-secD-secF Right R GATATCCCGGGCCTTGGGATATGGCTGCAGGTG
    VC2734-VC2723c Left F AACCTGTCGACAACGTTTGAGACACTTCGCTCCACT
    VC2734-VC2723 Left R GATATGAGCTCTTTGCGCATCATTACTCGCCAC
    VC2734-VC2723 Right F AACCTGAGCTCTGCCAAGAGAGCGTTGTGACCC
    VC2734-VC2723 Right R GATATCCCGGGTGGGCTCTGCAGCACTGAAAGC

qRT-PCR
    rpoD F AGGCAGTGGCTCACGACCCAT
    rpoD R ATGCGACTTGGTGGATCCGTCA
    ctxB F CCTCAGGGTATCCTTCATCCT
    ctxB R GTGCAGAATACCACAACACAC
    ctxA F ACGGCTCTTCCCTCCAAGCTCT
    ctxA R GGTATCGAGTTCATTTTGGGGTGC
    toxT F GCTGTCCTTTCTGAAGTGGTAA
    toxT R CTGCCCAACGCCAATTACGCGT
    toxR F ATTGGCTGGCTGCGGTGTGTTC
    toxR R TTGATCGCCCGAGTGGAAACG
    tcpP F GAGCGGATAAAAATTGAGTGGGGGA
    tcpP R CCCCGGTAACCTTGCTAAATCTCGT

a F, forward; R, reverse.

b Restriction enzyme recognition sequences are underlined.

c VC2734-VC2723 are genes encoding components of Type II secretion system.

Confocal Microscope

Differential interference contrast (DIC) and green fluorescent images were acquired using a confocal laser scanning microscope (FV-1000; Olympus Optical Co. Ltd., Japan) and its operating software, FV10-ASW (version 02.01). Detailed procedures are described elsewhere (16, 21). For ROS detection, N16961 was grown anaerobically for 8 h with 50 mm TMAO, DMSO, or fumarate. Aliquots of each culture were removed and stained with 10 μm DCF-DA (2′,7′-dichlorofluorescein diacetate, Sigma) for 30 min. To capture the green fluorescence, samples were scanned at 488 nm and emission was detected through a 520-nm band filter. The DIC and green fluorescence images were collected simultaneously.

Two-dimensional Gel Electrophoresis and Protein Identification

N16961 cells grown anaerobically for 16 h in LB, LBT, LBD, or LBF were harvested by centrifugation at 14,000 × g for 5 min. The cell pellet was washed three times with ice-cold PBS and submitted to Genomine Inc. (Pohang, Korea), where the entire proteomic analysis was performed.

Infant Mouse Infection

Infant mice (∼5 to 6 days old, Central Lab Animal Inc., Seoul) were orogastrically infected with V. cholerae strains following procedures previously described (3). After 24 h infection, intestinal homogenates were prepared and the number of viable cells was determined by spreading serial diluents on LB agar containing Sm (for total bacterial cell count) or LB agar containing both Sm and Km (for ΔtorD mutant).

qRT-PCR

Transcript levels of virulence-associated genes (ctxA, ctxB, toxT, toxR, and tcpP) were measured by qRT-PCR. The detailed analysis procedure has been described previously (21). Transcript levels of the rpoD gene were used to normalize the transcript levels of the tested genes. The primers used for qRT-PCR are listed in Table 2.

TMAO Reductase Activity Assay

V. cholerae strains, N16961, and four Tn-insertion mutants, were grown anaerobically in LB or LBT for 16 h. To analyze the TMAO reductase activity in different cellular fractions, the periplasmic and cytoplasmic fractions were separated by polymyxin B treatment. Cell pellets were resuspended with PBS containing 2,000 units of polymyxin B and incubated for 15 min at 4 °C. After incubation, reaction mixtures were centrifuged at 12,000 rpm for 10 min and the supernatants were saved for periplasmic fractions. Cell pellets were then resuspended in PBS and sonicated to produce cytoplasmic fractions. Equal amounts of proteins present in each fraction were resolved by a 9% nondenaturing polyacrylamide gel, and a native gel-based enzyme assay was performed as previously described (22).

Statistical Analysis

Data are expressed as mean ± S.D. An unpaired Student's t test was used to analyze the data. A p value of <0.05 was considered statistically significant. All experiments were repeated for reproducibility.

RESULTS

Anaerobic Growth of the V. cholerae Strain N16961 Was Enhanced by TMAO Respiration and CT Production Was Remarkably Induced under Such Conditions

V. cholerae was reported to support anaerobic growth by using diverse AEAs, such as TMAO, fumarate, and DMSO (15). To examine the relative anaerobic growth achieved using each AEA, N16961 was grown in LB supplemented with TMAO, fumarate, or DMSO at three different concentrations. As shown in Fig. 1A, bacterial growth was enhanced when grown with TMAO or fumarate. When TMAO was added at 50 mm concentration, the final A600 values were ∼2-fold higher than that of control growth in plain LB media (black bar to the left). N16961 also exhibited better anaerobic growth using fumarate with the growth enhancement being as robust as what was observed in TMAO-amended LB broth. Additional increases in the final A600 values were not observed when DMSO was used.

FIGURE 1.

FIGURE 1.

CT production is specifically induced during anaerobic growth by TMAO respiration in N16961. A, anaerobic growth of N16961 in the presence of AEAs. Bacterial cells precultured aerobically in LB were inoculated to LB media or to LB containing TMAO, fumarate, or DMSO and grown statically inside the anaerobic chamber for 16 h. To examine dose dependence, three different concentrations (50, 25, and 10 mm) of TMAO, fumarate, and DMSO were used. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. *, p < 0.01 versus A600 values of N16961 after anaerobic growth in plain LB. B, the effect of anaerobiosis and the presence of AEAs on CT production. N16961 was aerobically or anaerobically grown in LB with each AEA (50 mm) for 16 h. The CT level was determined by ELISA. *, p < 0.001 versus CT levels from other cultures. C, Western blot analysis of culture supernatants harvested from aerobic or anaerobic growth of N16961 in LB or LBT (LB + 50 mm TMAO). Prior to loading onto SDS-PAGE gel, each culture supernatant was concentrated by TCA precipitation. The protein band that corresponds to the CT subunit B was shown with an arrowhead. D, promoter activity of ctxAB genes in N16961 grown under the indicated culture conditions. An N16961 reporter strain harboring single-copy PctxAB::lacZ fusion was assayed in triplicate for β-galactosidase activity. Values of mean ± S.D. are presented. *, p < 0.001 versus β-galactosidase activity measured from other cultures. E, qRT-PCR analysis of V. cholerae virulence-associated genes. qRT-PCR was conducted on cDNA synthesized from 2 μg of total RNA extracted from N16961 grown anaerobically either in LB (black bars) or in LBT (gray bars). Bacterial cells were harvested after 8 h of growth and subjected to RNA isolation. Transcript levels of the tested genes indicated at the bottom were normalized with those of the rpoD gene transcript. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. The primers used for qRT-PCR are listed in Table 2. *, p < 0.05 versus transcript levels in N16961 grown in LB. F, Western blot analysis of CT subunit B in a variety of V. cholerae strains. Bacterial strains were grown anaerobically in LBT (except for the first lane; N16961 grown in LB) for 16 h and culture supernatants, concentrated via TCA precipitation, were loaded onto SDS-PAGE for Western blot analysis. Information on bacterial strains was provided in Table 1. The protein band that corresponds to the CT subunit B was shown with an arrowhead.

The level of CT secreted to culture supernatants during each anaerobic culture was then measured. Surprisingly, CT production was strikingly induced during TMAO-stimulated anaerobic respiratory growth (Fig. 1B). Such a dramatic induction was not detected in other types of anaerobic growth. Notably, CT was not produced when N16961 was grown aerobically with equal amounts of TMAO (Fig. 1B), demonstrating that TMAO-induced CT production occurred only under anaerobic growth conditions. To confirm the CT ELISA results, Western blot analysis was also performed using an antibody against CT subunit B. As shown in Fig. 1C, the band specific to CT subunit B was only detected in the cell-free culture supernatant of N16961 grown by anaerobic TMAO respiration. These results suggest that among various AEAs, TMAO can most efficiently stimulate anaerobic growth of the V. cholerae strain N16961. In addition, CT production is specifically and substantially induced during TMAO respiration.

The study also investigated whether TMAO-stimulated CT production was reflected in the transcriptional activation of CT-coding genes. To address this, the promoter activity of ctxAB genes was monitored by constructing a chromosomal lacZ reporter fusion to this promoter. Consistent with the CT ELISA results, a significant level of β-galactosidase activity was detected only in N16961 grown anaerobically in LB containing 50 mm TMAO (Fig. 1D). The mRNA expression levels of other virulence-associated genes were then measured by qRT-PCR analysis. Transcript levels of five selected genes, ctxA, ctxB, toxT, toxR, and tcpP, invariably increased in N16961 grown in LBT compared with LB (Fig. 1E). Expression of ctxA and tcpP was up-regulated to the highest level at greater than ∼50-fold, whereas the mRNA levels of ctxB, toxT, and toxR increased ∼13-, ∼17-, and ∼12-fold, respectively (Fig. 1E).

The 7th pandemic V. cholerae strain N16961 is classified as O1 serogroup and El Tor biotype (23). We therefore asked whether the mechanism of TMAO-stimulated CT production is conserved among other types of V. cholerae strains. Two different Classical biotype strains (O395 and 569B) and another O1 El Tor biotype strain (C6706) produced comparable CT levels under the same anaerobic growth conditions (Fig. 1F). Interestingly, both the O139 serogroup strain MO10 and the non-O1/non-O139 strain AM19226 failed to produce CT. As expected, CT was not produced in the CVD115 strain derived from CVD110 that has deletions in CT-coding genes (24) or in the N16961 strain grown in plain LB (leftmost lane). Although only a limited number of V. cholerae strains were tested, these results may suggest that the mechanism for producing CT during TMAO respiration is conserved in V. cholerae O1 serogroup strains.

CT Production Was Not Observed in N16961 Tn Insertion Mutants with Defects in Their Ability to Respire TMAO

To examine whether a mechanistic link exists between enhanced anaerobic growth by TMAO respiration and CT production, an N16961 Tn random insertion mutant library was constructed and screened for mutants that failed to form colonies with a larger size in LB-agar plates supplemented with 50 mm TMAO. In four mutants that were recovered, it was clearly shown that the presence of TMAO did not increase their anaerobic growth (Fig. 2A). In all of these mutants, the final A600 values after 16 h of anaerobic culture in LBT were similar to those obtained from LB growth. Arbitrary PCR amplification followed by DNA sequencing analysis demonstrated that Tn was inserted in the protein coding regions of VC1720, VC0116, VC2053, or VC1024, respectively (Fig. 2B). VC1720, termed torD, encodes a chaperone protein for TorA (VC1692), a major subunit of the TMAO reductase complex (25). VC0116 (HemN) is an oxygen-independent coproporphyrinogen III oxidase involved in heme biosynthesis (26, 27). VC2053 encodes a heme chaperone for biosynthesis of the c-type cytochrome that is required for active TMAO reductase (15). TMAO reductase is also featured with the presence of a molybdenum cofactor (28). A mutant of VC1024 (moaA) that is defective in the machinery required to synthesize the molybdenum cofactor was included among the mutants incapable of utilizing TMAO under anaerobic conditions. Consistent with this finding, the synthesis of molybdenum cofactor biosynthesis protein B produced from a gene (VC1025, moaB) clustered as an operon with moaA was specifically up-regulated in LBT-grown N16961 in two-dimensional gel electrophoresis analysis (Fig. 2C).

FIGURE 2.

FIGURE 2.

Identification of N16961 mutants defective in anaerobic growth by TMAO respiration. A, anaerobic growth of wild type N16961 and four different mutants recovered from screening Tn mutant library. Strains were grown anaerobically in LB (black bars) or LBT (gray bars) for 16 h, and values of A600 (mean ± S.D., n = 3) are displayed. *, p < 0.001 versus A600 values of other cultures. B, information of genes disrupted in each mutant and function of the proteins encoded from each gene. C, up-regulated synthesis of VC1025 protein in N16961 grown in LBT. Bacterial proteins were extracted from N16961 grown anaerobically in LB, LBT, LBD (LB + 50 mm DMSO), or LBF (LB + 50 mm fumarate) and were separated in two-dimensional gels. The same area of each gel containing a spot for VC1025 was compared. The VC1025 protein was identified by Q-TOF. The leftmost image represents protein spots detected by gel image analysis.

The TMAO reductase activity in each mutant was then measured by a native gel-based assay (22). As expected, TMAO reductase activity was robustly induced in N16961 grown anaerobically in LBT, but not in LB (Fig. 3A). TMAO reductase was detected in both the periplasm and cytoplasmic space in LBT-grown N16961. TMAO reductase was non-detectable in the ΔVC1720 and ΔVC1024 mutants, whereas its activity was significantly decreased in the ΔVC0116 and ΔVC2053 mutants (Fig. 3A). These results further confirm that the incapability of these mutants to exhibit enhanced anaerobic growth using TMAO is indeed caused by the presence of defective TMAO reductase.

FIGURE 3.

FIGURE 3.

TMAO reductase activity detected in the recovered mutants and their capabilities to produce CT. A, strains indicated at the bottom were grown anaerobically in LB or in LBT for 16 h. Proteins present in cytoplasmic (C) and periplasmic (P) fractions were separated by native gel and stained for TMAO reductase activity. One μg of protein was subjected to native gel electrophoresis and activity staining in each lane. The activity staining was performed as described under “Experimental Procedures.” B, CT ELISA analysis of mutant strains. Experimental conditions were identical to those described in the legend to Fig. 1B. *, p < 0.001 versus CT levels from other cultures.

We then examined whether or not these mutants have compromised capabilities to produce CT. As shown in Fig. 3B, the CT levels induced in all of these mutant strains were negligible during anaerobic growth with TMAO, whereas robust CT production was observed in the wild type strain N16961. Together, our results demonstrate that (i) the ability to produce heme group, cytochrome c, and molybdenum cofactor is necessary to produce functionally intact TMAO reductase and (ii) that CT production during anaerobiosis occurs in strict association with TMAO respiration.

The Twin Arginine Transport Pathway Was Required for Both TMAO Respiration and CT Production

TMAO reductase is active in the periplasmic space and is transported to the periplasm via the twin arginine transport (TAT) system in Escherichia coli (29). The bacterial TAT system is an inner membrane-associated apparatus for protein translocation that can export cytoplasmic proteins containing a consensus twin arginine recognition motif in its N terminus (30). To elucidate whether TMAO reductase of V. cholerae is also processed in a similar way, we first analyzed the primary sequence of TMAO reductase, the product of torA gene (VC1692). As shown in Fig. 4A, TMAO reductase of V. cholerae strain N16961 also harbors the twin arginine motif in its N-terminal region, suggesting that this enzyme is likely a substrate of the TAT system. Unlike E. coli, in which the torA, torC, and torD genes are clustered as an operon (31), the torD gene is located in a separate region of the N16961 genome (Fig. 4A). TorC is a cytochrome c-type subunit of TMAO reductase (32).

FIGURE 4.

FIGURE 4.

Involvement of the TAT pathway in anaerobic TMAO respiration and CT production. A, chromosomal location of torA, torC, and torD genes is depicted. Twin arginine recognition motif in the N-terminal region of the TorA protein is indicated. B, anaerobic growth of N16961, Δtat, Δsec, and Δtype II mutant strains in LB (black bars) or LBT (gray bars). Experimental conditions were identical to those described in the legend to Fig. 1A. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. *, p < 0.01 versus A600 values obtained from growth in plain LB. C, CT production of N16961, Δtat, Δsec, and Δtype II mutant strains grown in LB (black bars) or LBT (gray bars). Experimental conditions were identical to those described in the legend to Fig. 1B. *, p < 0.001; **, p < 0.01 versus CT levels detected in cell-free supernatants harvested from LB grown cells.

We then constructed a Δtat mutant in which three genes (tatA, tatB, and tatC) of the TAT operon were deleted and tested whether such a mutant can exhibit enhanced anaerobic growth on TMAO. As shown in Fig. 4B, no growth enhancement was observed in the Δtat mutant in response to the presence of TMAO, demonstrating that the TAT system is critically required for activation of the TMAO reductase in V. cholerae. Importantly, CT was not produced in the Δtat mutant during anaerobic growth in LBT (Fig. 4C). This result further suggests that CT production is specifically induced only under conditions in which bacterial anaerobic growth is stimulated by TMAO respiration.

It is well established that CT is secreted into the environmental milieu from the periplasmic space via a type II secretion system (T2SS) in V. cholerae (33, 34). For facilitated transport across the inner membrane into the periplasm, CT is targeted to either the general secretion pathway (SEC) (35, 36) or the TAT system (22). For this reason, we also examined the effects of SEC or T2SS deficiency on anaerobic TMAO respiration and CT secretion. The ability to support anaerobic growth by TMAO respiration was not affected in N16961 Δsec and Δtype II mutants, respectively (Fig. 4B). The extent to which anaerobic growth was increased by TMAO respiration in each of these two mutants was almost identical to that observed in N16961. The CT level detected in cell-free culture supernatants of the Δsec mutant was only mildly decreased. As anticipated, CT production was substantially decreased in the Δtype II mutant grown anaerobically in LBT (Fig. 4C), further verifying that T2SS is the predominant route for CT secretion to the environment. These results also suggest that the TAT system plays a more important role than SEC in CT secretion during anaerobic growth with TMAO.

Reactive Oxygen Species (ROS) Is Produced during TMAO Respiration whereas CT Production Was Antagonized by the Presence of N-Acetylcysteine, a ROS Scavenger

During TMAO reduction to TMA, an oxygen atom is liberated from TMAO via a reaction that involves the oxidation of a molybdenum cofactor present in the TorA subunit (3739). Hence, we hypothesized that ROS might be generated during this reaction. To address this issue, N16961 cells grown in various culture media were stained with DCF-DA, a fluorescent dye that reacts specifically with ROS (40). Fig. 5, A–D, shows confocal images of N16961 grown anaerobically in LB, LBT, LBF, or LBD, respectively. The first image in each panel is a merged DIC and fluorescent image, whereas the second is a green fluorescent image. The green fluorescence signal was only faintly visible in N16961 cells grown in LB, suggesting that ROS is minimally produced during anaerobic growth in LB (Fig. 5A). The fluorescent signal in cells grown in LBD was comparable with that detected in LB-grown N16961 cells (Fig. 5D), whereas the signal was not detectable in cells grown in LBF (Fig. 5C). Importantly, a large population of LBT-grown cells produced fluorescent signals that were significantly more intense than those detected in other groups (Fig. 5B). Together, these results suggest that ROS is likely produced as a result of TMAO respiration. The results provide strong clues that this undesirable by-product may trigger a cellular mechanism that leads to CT production in N16961.

FIGURE 5.

FIGURE 5.

ROS is spontaneously generated during anaerobic TMAO respiration. Confocal microscope images of N16961 grown anaerobically in LB (A), LBT (B), LBF (C), and LBD (D). LBF and LBD indicate LB + 50 mm fumarate and LB + 50 mm DMSO, respectively. Left images in each panel represent merged DIC and green fluorescent images, whereas right images represent only green fluorescent images. Bacterial cells grown in each media for 8 h were strained with 10 μm DCF-DA for 30 min and processed for confocal microscopic analysis. Images were acquired at ×1,000 magnification.

Next, we tested the effect of N-acetylcysteine (NAC), a ROS scavenger, on CT production and ctxAB promoter activity. In the presence of increasing amounts of NAC, the CT level induced during anaerobic growth by TMAO respiration was gradually decreased (Fig. 6A). Likewise, a clear dose-dependent decrease was also observed in the PctxAB activity (Fig. 6B). These results suggest that ROS availability can regulate the degree of ctxAB gene expression and CT production. We then investigated whether the CT production level is elevated by exogenous addition of H2O2. When N16961 was grown anaerobically in LB media that contained increasing concentrations of TMAO, CT production was gradually increased (Fig. 6C, black bars). The level of CT produced during TMAO respiration significantly increased in the presence of 100 μm H2O2 (Fig. 6C, gray bars). During anaerobic growth with 20 or 30 mm TMAO, CT production increased by ∼1.8- or ∼1.9-fold, respectively, with the addition of 100 μm H2O2. When grown with 40 or 50 mm TMAO, CT production increased ∼1.5-fold in the presence of H2O2 compared with growth in its absence. Notably, CT production was not induced by H2O2 when bacterial cells were grown in plain LB (Fig. 6C, leftmost set of bars). In addition, H2O2–mediated stimulation of CT production was not observed when fumarate or DMSO were used to support anaerobic growth of N16961 (Fig. 6, D and E). These results suggest that H2O2, an exogenously added ROS, can promote CT production only when V. cholerae cells grow by anaerobic TMAO respiration.

FIGURE 6.

FIGURE 6.

Extraneously added H2O2 promotes CT production during anaerobic TMAO respiration. A, effect of the presence of NAC on CT production. N16961 cells were grown anaerobically in LBT for 16 h with the indicated amounts of NAC. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. *, p < 0.01; **, p < 0.001 versus CT levels detected in cell-free supernatants harvested from cultures with 0 mm NAC. B, the effect of the presence of NAC on ctxAB promoter activity. An N16961 reporter strain harboring a chromosomal copy of ctxAB promoter-lacZ fusion was grown anaerobically in LBT in the presence of increasing concentrations of NAC. Bacterial culture conditions were identical to those described in the legend to Fig. 6A and β-galactosidase activity was measured as described in the legend to Fig. 1D. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. **, p < 0.001 versus β-galactosidase activity detected in cells grown with 0 mm NAC. C–E, effect of extraneously added H2O2 on CT production. LB media with varying concentrations of TMAO (C), fumarate (D), or DMSO (E) were supplemented with no (black bars) or 100 μm H2O2 (gray bars). N16961 was grown anaerobically in each media for 16 h and culture supernatants were collected for CT ELISA. Three independent experiments were performed and values of mean ± S.D. are displayed in each bar. *, p < 0.01 versus CT levels produced without added H2O2.

When Infected with TMAO, the Cytotoxicity Exerted by V. cholerae Strains Was Elevated in Infant Mouse Intestine

Finally, we sought to examine the effect of TMAO on in vivo virulence using an infant mouse model of V. cholerae infection. We first measured the fluid accumulation induced by orogastric challenge of V. cholerae N16961 cells (2 × 106 cells). Higher levels of the intestinal fluid accumulation ratio were observed in mice infected with bacterial cells re-suspended in LB + 100 mm TMAO (fluid accumulation ratio > ∼0.12) than in mice infected with bacterial suspensions that contain no TMAO (fluid accumulation ratio > ∼0.08) (Fig. 7A). Importantly, mice infected with extraneously added TMAO exhibited higher susceptibility in response to intestinal infection. Although all of the mice infected with bacterial suspensions in plain LB survived for 24 h, only one mouse survived at 24 h post-infection when TMAO was added to the inoculum (Fig. 7B). These results suggest that V. cholerae strains exert more severe virulence to infant mice in the presence of added TMAO.

FIGURE 7.

FIGURE 7.

Effects of TMAO on in vivo virulence and colonization. A, infant mice (n = 7) were infected with N16961 cells (2 × 106cells) suspended in LB (left bar) or LB + 100 mm TMAO (right bar). After 24 h, mice were sacrificed and the entire intestines were extracted for weight measurement. Fluid accumulation ratio was calculated as intestine weight divided by (body weight − intestine weight). For infection with TMAO, the increase in FAR was statistically significant (*, p < 0.005). B, identical set of mice used in experiments described in panel A were examined to check their viability every 3 h. Percent survival in each group was plotted with time. C, mice were co-infected with an equal number of N16961 and ΔtorD mutant (1 × 106 cells, each). Again, bacterial cells were resuspended in LB or LB containing 100 mm TMAO. The competitive index represents the ratio of N16961 to ΔtorD mutant recovered after infection. Seven mice were used for each infection and mean ± S.D. are presented (*, p < 0.005 versus competitive index obtained from infection with no added TMAO).

Our results in Fig. 2A demonstrate that wild type N16961, but not the ΔtorD mutant, exhibited enhanced in vitro growth by TMAO respiration. Therefore, we investigated whether in vivo colonization of the ΔtorD mutant is compromised, compared with the wild type strain. To address this issue, we calculated the competitive index between these two strains. Infant mice (n = 7) were co-infected with equal numbers of N16961 and ΔtorD mutant cells re-suspended in LB or LBT (1 × 106 cells each). When TMAO was not added to the inoculum, the level of intestinal colonization by N16961 was slightly less than that of the ΔtorD mutant, yielding a competitive index of ∼0.77 (Fig. 7C, closed circles). In contrast, when the mixture of bacterial cells was inoculated with 100 mm TMAO, the number of N16961 cells was higher than that of the mutant cells (Fig. 7C, closed squares). The competitive index in this set of experiments was ∼1.78 and the difference between the two competitive indexes was statistically significant (p < 0.005). Together, these results suggest that the ability to metabolize TMAO may be important not only for in vivo virulence but also for intestinal colonization.

DISCUSSION

As a historic enteric pathogen, V. cholerae has been extensively investigated for the regulation of virulence factors. For successful colonization and CT production in host intestinal microenvironments, the organism must alter its phenotypic and metabolic properties from those of its natural aquatic habitat. Because the human intestinal environment is largely anaerobic (7, 41), there is a need for the pathogen to utilize chemicals other than oxygen as AEAs for anaerobic growth. V. cholerae is reported to be capable of metabolizing organic amines including TMAO and fumarate under anaerobic growth conditions (15). However, there is a lack of information regarding the effect of anaerobic respiration on bacterial growth or regulated production of virulence factors for an in vitro culture system that resembles the human intestinal microenvironment.

CT is the major virulence factor that critically influences V. cholerae pathogenesis. Although genetic regulatory systems leading to activation of ctxAB gene expression are relatively well established (4, 42, 43), environmental signals that induce CT expression are not clearly defined. The AKI condition, which has been considered as an efficient in vitro culture method for CT production, involves a biphasic growth of the 4-h static culture followed by vigorous shaking for 16 h (44, 45). In addition, the volume-to-surface ratio of laboratory flask cultures was reported to play a role in regulating CT production (46). Because these culture methods were all developed by trial and error, why they trigger CT production is still unknown. In this study, we identified a previously undescribed culture condition that induces CT production and investigated the molecular basis of such induction and its relevance for in vivo infection.

Our conclusion that CT production was specifically induced when V. cholerae grew by anaerobic TMAO respiration stems from the following evidence: (i) CT production was not induced by other AEAs and (ii) ΔtorD and Δtat mutant strains of N16961 failed to produce CT during TMAO respiration. Because the anaerobic growth of V. cholerae was higher with TMAO than with fumarate or DMSO, we postulated that TMAO respiration can provide both a growth advantage to V. cholerae under anaerobic conditions and a significantly elevated potential for virulence. Consistent with this notion, the infant mouse infection experiments clearly demonstrated effects of extraneously added TMAO on in vivo virulence and competitive intestinal colonization.

In humans, TMAO is produced via an enzyme called flavin-containing monooxygenase, which catalyzes TMA oxidation. TMA is derived from ingested food sources, such as phosphatidylcholine and l-carnitine (47). In a recent study by Wang et al., TMAO was not detected in mice when gut microbiota were suppressed by treatment with antibiotics for 3 weeks (54). The TMAO level was restored after the mouse gut was recolonized by gut microbiota, indicating the key role of gut commensal bacteria for TMAO production (54). As our results showed that CT production could be induced in N16961 with as low as 10 mm TMAO, it seems necessary to determine how much TMAO is present in the human intestine and whether such a level is enough to support both anaerobic growth and CT production of V. cholerae in vivo. Furthermore, it would also be of particular interest to examine the correlation between the altered gut microbiota population profiles and differential susceptibility to V. cholerae infection. Because TMAO is mainly found in marine environments (48, 49), individuals with a marine diet may have elevated levels of TMAO in their intestine and be at a higher risk for pathogenic V. cholerae infection.

Proteins secreted by the Type II secretion system are translocated to the periplasm via the general secretion (SEC) system (50, 51) or TAT system (52). However, our results showed that CT secretion was not significantly compromised in the Δsec mutant, demonstrating that CT secretion likely occurs independently of the SEC pathway during anaerobic growth by TMAO respiration. This finding was rather unexpected because the SEC pathway was reported to be critical for CT secretion during aerobic growth (35, 36). In a recent study by Zhang and colleagues (22), CT production in a V. cholerae mutant deficient in the TAT pathway was only mildly affected during aerobic growth under AKI conditions. This result is also in marked contrast to our finding that CT production was completely abrogated in the Δtat mutant during anaerobic TMAO respiration. Together, these results suggest that CT secretion during anaerobic TMAO respiration may occur following different mechanisms than those operational during aerobic growth.

Our results in Fig. 5 clearly demonstrate that N16961 cells grown anaerobically with TMAO exhibited a strong fluorescent signal when stained with DCF-DA, a ROS detector. Because the fluorescent signal was only detected in cells grown by TMAO respiration, the growth mode that resulted in CT production, we postulated that ROS generated during TMAO respiration would trigger a signal leading to CT production. In support of this hypothesis is the finding that both CT production and ctxAB gene transcription decreased in the presence of NAC, a compound that can reduce the availability of cellular ROS. TMAO reductase reduces TMAO to TMA. Because TMA is the only product of TMAO reductase, it was also postulated that TMA might be the signal to induce CT production. However, neither growth enhancement nor CT production was observed when N16961 was grown anaerobically with 50 mm TMA (data not shown). This result further confirms that a signal leading to the CT production (i.e. ROS) is generated during TMAO reduction. The level of CT produced during TMAO respiration was substantially elevated when the culture medium was “spiked” with H2O2. However, the positive effect of H2O2 on CT production was not observed in N16961 grown in plain LB. These results strongly suggest that (i) H2O2 alone may not directly induce CT production in V. cholerae under anaerobic conditions and (ii) extraneously added H2O2 can play a role in expanding the capability of V. cholerae to produce CT during TMAO respiration. One possible interpretation would be that anaerobic TMAO respiration contributes to create conditions for CT production and such conditions are further amplified by the addition of extraneous H2O2. Interestingly, at up to 0.1% concentration (∼28 mm), H2O2 was found to increase the TcpA level in another El Tor strain, A1552, during aerobic growth in LB (53). In contrast, our results showed that only 100 μm H2O2 was enough to promote maximum CT production. It will be necessary to address (i) how much ROS is generated during TMAO respiration, (ii) how potent is it to transduce virulence inducing signals, and (iii) what is the mode of signal transduction. Because CT subunits A and B do not contain the twin arginine motif, a precise mechanism by which CT secretion occurs in association with the activated TAT pathway also needs to be elucidated.

In conclusion, we explored anaerobiosis-induced changes in growth and virulence properties of V. cholerae. Most importantly, we proposed a mechanistic basis for a strict dependence of CT production on the anaerobic TMAO respiration (summarized in Fig. 8). To identify effective strategies to cope with V. cholerae infection, a molecular level understanding of its virulence modulation is necessary. Our results revealed a previously unidentified mechanism for CT production under conditions that likely mimic the environments of the human intestine and therefore, we anticipate that results provided in this study will stimulate further investigations to reduce the severity of intestinal infections caused by this clinically important human pathogen.

FIGURE 8.

FIGURE 8.

Summary of potential mechanisms by which CT is produced during anaerobic TMAO respiration. A, in the presence of TMAO, the TAT pathway is activated to translocate TMAO reductase to the periplasmic space. B, ROS, generated during TMAO reduction to TMA, can stimulate a signal to activate ctxAB gene transcription for a mechanism that needs to be further investigated. C, presumably, CT subunits take advantage of the activated TAT pathway to be translocated into the periplasm. D, CT is excreted into the environmental milieu via the type II secretion pathway. For a simple presentation, the type II secretion apparatus present only in the outer membrane portion is depicted.

*

This work was supported by grants from the National Research Foundation of Korea (NRF), funded by Korean Government (MEST) Grants 2009–0087951 and 2011–0016210. This work was also supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Grant A110096 and Yonsei University College of Medicine Research Grant 6-2011-0101.

3
The abbreviations used are:
CT
cholera toxin
TMAO
trimethylamine N-oxide
TMA
trimethylamine
DCF-DA
2′,7′-dichlorofluorescein diacetate
AEA
alternative electron acceptors
DMSO
dimethyl sulfoxide
DIC
differential interference contrast
Tn
transposon
TAT
twin arginine transport
NAC
N-acetylcysteine
TCP
toxin co-regulated pilus.

REFERENCES

  • 1. Faruque S. M., Albert M. J., Mekalanos J. J. (1998) Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol. Mol. Biol. Rev. 62, 1301–1314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Piarroux R., Barrais R., Faucher B., Haus R., Piarroux M., Gaudart J., Magloire R., Raoult D. (2011) Understanding the cholera epidemic, Haiti. Emerg. Infect. Dis. 17, 1161–1168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Yoon S. S., Coakley R., Lau G. W., Lymar S. V., Gaston B., Karabulut A. C., Hennigan R. F., Hwang S. H., Buettner G., Schurr M. J., Mortensen J. E., Burns J. L., Speert D., Boucher R. C., Hassett D. J. (2006) Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116, 436–446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Matson J. S., Withey J. H., DiRita V. J. (2007) Regulatory networks controlling Vibrio cholerae virulence gene expression. Infect. Immun. 75, 5542–5549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Spangler B. D. (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56, 622–647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Iredell J. R., Manning P. A. (1994) The toxin-co-regulated pilus of Vibrio cholerae O1. A model for type 4 pilus biogenesis? Trends Microbiol. 2, 187–192 [DOI] [PubMed] [Google Scholar]
  • 7. Bäckhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. (2005) Host-bacterial mutualism in the human intestine. Science 307, 1915–1920 [DOI] [PubMed] [Google Scholar]
  • 8. Marrero K., Sánchez A., Rodríguez-Ulloa A., González L. J., Castellanos-Serra L., Paz-Lago D., Campos J., Rodríguez B. L., Suzarte E., Ledón T., Padrón G., Fando R. (2009) Anaerobic growth promotes synthesis of colonization factors encoded at the Vibrio pathogenicity island in Vibrio cholerae El Tor. Res. Microbiol. 160, 48–56 [DOI] [PubMed] [Google Scholar]
  • 9. Häse C. C., Mekalanos J. J. (1998) TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae. Proc. Natl. Acad. Sci. U.S.A. 95, 730–734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Liu Z., Yang M., Peterfreund G. L., Tsou A. M., Selamoglu N., Daldal F., Zhong Z., Kan B., Zhu J. (2011) Vibrio cholerae anaerobic induction of virulence gene expression is controlled by thiol-based switches of virulence regulator AphB. Proc. Natl. Acad. Sci. U.S.A. 108, 810–815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kovacikova G., Lin W., Skorupski K. (2010) The LysR-type virulence activator AphB regulates the expression of genes in Vibrio cholerae in response to low pH and anaerobiosis. J. Bacteriol. 192, 4181–4191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Nobechi K. (1925) Contributions to the knowledge of Vibrio cholerae I. Fermentation of carbohydrates and polyatomic alcohols by Vibrio cholerae. J. Bacteriol. 10, 197–215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Konishi K., Yamagishi T., Sakamoto K. (1981) A Halophilic vibrio isolated from a case of chronic cholecystitis. Microbiol. Immunol. 25, 1221–1228 [DOI] [PubMed] [Google Scholar]
  • 14. Nicholls K. M., Lee J. V., Donovan T. J. (1976) An evaluation of commercial thiosulfate citrate bile salt sucrose agar (TCBS). J. Appl. Bacteriol. 41, 265–269 [DOI] [PubMed] [Google Scholar]
  • 15. Braun M., Thöny-Meyer L. (2005) Cytochrome c maturation and the physiological role of c-type cytochromes in Vibrio cholerae. J. Bacteriol. 187, 5996–6004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lee K. M., Go J., Yoon M. Y., Park Y., Kim S. C., Yong D. E., Yoon S. S. (2012) Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa. Infect. Immun. 80, 1639–1649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Gardel C. L., Mekalanos J. J. (1994) Regulation of cholera toxin by temperature, pH, and osmolarity. Methods Enzymol. 235, 517–526 [DOI] [PubMed] [Google Scholar]
  • 18. Miyata S. T., Kitaoka M., Brooks T. M., McAuley S. B., Pukatzki S. (2011) Vibrio cholerae requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect. Immun. 79, 2941–2949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Lee K. M., Yoon M. Y., Park Y., Lee J. H., Yoon S. S. (2011) Anaerobiosis-induced loss of cytotoxicity is due to inactivation of quorum sensing in Pseudomonas aeruginosa. Infect. Immun. 79, 2792–2800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Philippe N., Alcaraz J. P., Coursange E., Geiselmann J., Schneider D. (2004) Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51, 246–255 [DOI] [PubMed] [Google Scholar]
  • 21. Yoon M. Y., Lee K. M., Park Y., Yoon S. S. (2011) Contribution of cell elongation to the biofilm formation of Pseudomonas aeruginosa during anaerobic respiration. PLoS ONE 6, e16105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Zhang L., Zhu Z., Jing H., Zhang J., Xiong Y., Yan M., Gao S., Wu L. F., Xu J., Kan B. (2009) Pleiotropic effects of the twin arginine translocation system on biofilm formation, colonization, and virulence in Vibrio cholerae. BMC Microbiol. 9, 114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Heidelberg J. F., Eisen J. A., Nelson W. C., Clayton R. A., Gwinn M. L., Dodson R. J., Haft D. H., Hickey E. K., Peterson J. D., Umayam L., Gill S. R., Nelson K. E., Read T. D., Tettelin H., Richardson D., Ermolaeva M. D., Vamathevan J., Bass S., Qin H., Dragoi I., Sellers P., McDonald L., Utterback T., Fleishmann R. D., Nierman W. C., White O., Salzberg S. L., Smith H. O., Colwell R. R., Mekalanos J. J., Venter J. C., Fraser C. M. (2000) DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406, 477–483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Michalski J., Galen J. E., Fasano A., Kaper J. B. (1993) CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immun. 61, 4462–4468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Pommier J., Méjean V., Giordano G., Iobbi-Nivol C. (1998) TorD, a cytoplasmic chaperone that interacts with the unfolded trimethylamine N-oxide reductase enzyme (TorA) in Escherichia coli. J. Biol. Chem. 273, 16615–16620 [DOI] [PubMed] [Google Scholar]
  • 26. Layer G., Verfürth K., Mahlitz E., Jahn D. (2002) Oxygen-independent coproporphyrinogen-III oxidase HemN from Escherichia coli. J. Biol. Chem. 277, 34136–34142 [DOI] [PubMed] [Google Scholar]
  • 27. Al-Sheboul S., Saffarini D. (2011) Identification and analysis of the Shewanella oneidensis major oxygen-independent coproporphyrinogen III oxidase gene. Anaerobe 17, 501–505 [DOI] [PubMed] [Google Scholar]
  • 28. Dos Santos J. P., Iobbi-Nivol C., Couillault C., Giordano G., Méjean V. (1998) Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J. Mol. Biol. 284, 421–433 [DOI] [PubMed] [Google Scholar]
  • 29. Santini C. L., Ize B., Chanal A., Müller M., Giordano G., Wu L. F. (1998) A novel sec-independent periplasmic protein translocation pathway in Escherichia coli. EMBO J. 17, 101–112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Lee P. A., Tullman-Ercek D., Georgiou G. (2006) The bacterial twin arginine translocation pathway. Annu. Rev. Microbiol. 60, 373–395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Méjean V., Iobbi-Nivol C., Lepelletier M., Giordano G., Chippaux M., Pascal M. C. (1994) TMAO anaerobic respiration in Escherichia coli. Involvement of the tor operon. Mol. Microbiol. 11, 1169–1179 [DOI] [PubMed] [Google Scholar]
  • 32. Gon S., Giudici-Orticoni M. T., Méjean V., Iobbi-Nivol C. (2001) Electron transfer and binding of the c-type cytochrome TorC to the trimethylamine N-oxide reductase in Escherichia coli. J. Biol. Chem. 276, 11545–11551 [DOI] [PubMed] [Google Scholar]
  • 33. Johnson T. L., Abendroth J., Hol W. G., Sandkvist M. (2006) Type II secretion. From structure to function. FEMS Microbiol. Lett. 255, 175–186 [DOI] [PubMed] [Google Scholar]
  • 34. Cianciotto N. P. (2005) Type II secretion. A protein secretion system for all seasons. Trends Microbiol. 13, 581–588 [DOI] [PubMed] [Google Scholar]
  • 35. Sandkvist M., Bagdasarian M., Howard S. P. (2000) Characterization of the multimeric Eps complex required for cholera toxin secretion. Int. J. Med. Microbiol. 290, 345–350 [DOI] [PubMed] [Google Scholar]
  • 36. Sandkvist M., Michel L. O., Hough L. P., Morales V. M., Bagdasarian M., Koomey M., DiRita V. J. (1997) General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J. Bacteriol. 179, 6994–7003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Barrett E. L., Kwan H. S. (1985) Bacterial reduction of trimethylamine oxide. Annu. Rev. Microbiol. 39, 131–149 [DOI] [PubMed] [Google Scholar]
  • 38. McCrindle S. L., Kappler U., McEwan A. G. (2005) Microbial dimethylsulfoxide and trimethylamine N-oxide respiration. Adv. Microb. Physiol. 50, 147–198 [DOI] [PubMed] [Google Scholar]
  • 39. Ilbert M., Méjean V., Giudici-Orticoni M. T., Samama J. P., Iobbi-Nivol C. (2003) Involvement of a mate chaperone (TorD) in the maturation pathway of molybdoenzyme TorA. J. Biol. Chem. 278, 28787–28792 [DOI] [PubMed] [Google Scholar]
  • 40. Chandel N. S., Trzyna W. C., McClintock D. S., Schumacker P. T. (2000) Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J. Immunol. 165, 1013–1021 [DOI] [PubMed] [Google Scholar]
  • 41. Taylor C. T., Colgan S. P. (2007) Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 [DOI] [PubMed] [Google Scholar]
  • 42. DiRita V. J. (1992) Coordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6, 451–458 [DOI] [PubMed] [Google Scholar]
  • 43. Klose K. E. (2001) Regulation of virulence in Vibrio cholerae. Int. J. Med. Microbiol. 291, 81–88 [DOI] [PubMed] [Google Scholar]
  • 44. Iwanaga M., Yamamoto K., Higa N., Ichinose Y., Nakasone N., Tanabe M. (1986) Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol. Immunol. 30, 1075–1083 [DOI] [PubMed] [Google Scholar]
  • 45. Iwanaga M., Yamamoto K. (1985) New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor. J. Clin. Microbiol. 22, 405–408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Sánchez J., Medina G., Buhse T., Holmgren J., Soberón-Chavez G. (2004) Expression of cholera toxin under non-AKI conditions in Vibrio cholerae El Tor induced by increasing the exposed surface of cultures. J. Bacteriol. 186, 1355–1361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Lang D. H., Yeung C. K., Peter R. M., Ibarra C., Gasser R., Itagaki K., Philpot R. M., Rettie A. E. (1998) Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes. Selective catalysis by FMO3. Biochem. Pharmacol. 56, 1005–1012 [DOI] [PubMed] [Google Scholar]
  • 48. Martinez I., Bathen T., Standal I. B., Halvorsen J., Aursand M., Gribbestad I. S., Axelson D. E. (2005) Bioactive compounds in cod (Gadus morhua) products and suitability of 1H NMR metabolite profiling for classification of the products using multivariate data analyses. J. Agric. Food Chem. 53, 6889–6895 [DOI] [PubMed] [Google Scholar]
  • 49. Bordi C., Ansaldi M., Gon S., Jourlin-Castelli C., Iobbi-Nivol C., Méjean V. (2004) Genes regulated by TorR, the trimethylamine oxide response regulator of Shewanella oneidensis. J. Bacteriol. 186, 4502–4509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Pugsley A. P. (1993) The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57, 50–108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Desvaux M., Parham N. J., Scott-Tucker A., Henderson I. R. (2004) The general secretory pathway. A general misnomer? Trends Microbiol. 12, 306–309 [DOI] [PubMed] [Google Scholar]
  • 52. Voulhoux R., Ball G., Ize B., Vasil M. L., Lazdunski A., Wu L. F., Filloux A. (2001) Involvement of the twin arginine translocation system in protein secretion via the type II pathway. EMBO J. 20, 6735–6741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Valeru S. P., Rompikuntal P. K., Ishikawa T., Vaitkevicius K., Sjöling A., Dolganov N., Zhu J., Schoolnik G., Wai S. N. (2009) Role of melanin pigment in expression of Vibrio cholerae virulence factors. Infect. Immun. 77, 935–942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., Feldstein A. E., Britt E. B., Fu X., Chung Y. M., Wu Y., Schauer P., Smith J. D., Allayee H., Tang W. H., DiDonato J. A., Lusis A. J., Hazen S. L. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES